Minoru Hasegawa

18.1k citations
392 papers · 12.6k indexed · 1 hit paper · h-index 62

Minoru Hasegawa

377 papers receiving 12.4k citations

Hit Papers

Safety and efficacy of rituximab in systemic sclerosis (D...14220212026202220244080120

Peers

Minoru Hasegawa
Comparison fields: 5 of 169
  • Pathology and Forensic Medicine 5.8k
  • Dermatology 2.4k
  • Immunology 4.0k
  • Rheumatology 2.2k
  • Immunology and Allergy 471
Replace Manabu Fujimoto with:
Manabu Fujimoto Japan
John Varga United States
Osamu Ishikawa Japan
Marvin J. Fritzler Canada
Tadashi Yoshino Japan
Michael Detmar Switzerland
Masashi Fukayama Japan
Jan Damoiseaux Netherlands
Roland Kaufmann Germany
Lalage M. Wakefield United States
Minoru Hasegawa relative to Manabu Fujimoto Japan Manabu Fujimoto's profile →
Citations per field
00.5×1.5×
Manabu Fujimoto · 1×
Citations per year

Countries citing papers authored by Minoru Hasegawa

Since Specialization
Citations

This map shows the geographic impact of Minoru Hasegawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minoru Hasegawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minoru Hasegawa more than expected).

Fields of papers citing papers by Minoru Hasegawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minoru Hasegawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minoru Hasegawa. The network helps show where Minoru Hasegawa may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Minoru Hasegawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Minoru Hasegawa Line = papers co-authored together Minoru Hasegawa links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20240
3 20240
4 20241
5 20203
6 201917
7 201913
8 201861
9 2018111
10 201731
11 20176
12 201652
13 201241
14
Fas-Associated Factor 1 is a negative regulator of PYRIN-containing Apaf-1-like protein 1
200918
15
Mechanism of ASC-mediated apoptosis : Bid-dependent apoptosis in type II cells
200742
16 200686
17 2006165
18 19981
19 19951
20 19701

About Minoru Hasegawa

Minoru Hasegawa is a scholar working on Pathology and Forensic Medicine, Dermatology and Rheumatology, having authored 392 papers that have together received 12.6k indexed citations. Recurring topics across this work include Systemic Sclerosis and Related Diseases (156 papers), Autoimmune Bullous Skin Diseases (63 papers), Inflammatory Myopathies and Dermatomyositis (45 papers), Mast cells and histamine (33 papers), Dermatologic Treatments and Research (31 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (31 papers), Eosinophilic Disorders and Syndromes (28 papers) and Cell Adhesion Molecules Research (24 papers). The work is most often cited by research in Pathology and Forensic Medicine (5.8k citations), Dermatology (2.4k citations) and Immunology (4.0k citations). Minoru Hasegawa has collaborated with scholars based in Japan, United States and Poland. Frequent co-authors include Kazuhiko Takehara, Shinichi Sato, Manabu Fujimoto, Takashi Matsushita, Yasuhito Hamaguchi, Thomas F. Tedder, Kazuhiro Komura, Koichi Yanaba, Fumihide Ogawa and Masanari Kodera. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026